These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8051794

  • 1. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
    Hirakawa K, Tsuda S, Misawa S, Ueda Y, Kaneko H, Nakao M, Ariyama Y, Nakai H, Seriu T, Takashima T.
    Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders].
    Seriu T, Tsuda S, Nakai H, Murakami T, Takashima T, Takahashi Y, Tanaka S, Nakagawa H, Nishigaki H, Yokota S.
    Jpn J Antibiot; 1991 Nov; 44(11):1197-205. PubMed ID: 1784070
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
    Tsuda S, Kuzuyama Y, Nakai H, Seriu T, Takashima T, Tanaka S, Horiike S, Taniwaki M, Misawa S, Kashima K.
    Jpn J Antibiot; 1993 Feb; 46(2):171-83. PubMed ID: 8331778
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H, Yamao H, Saito H, Ohno R, Hotta T, Ohnishi K, Murate T, Kagami Y, Mitomo Y, Nitta M.
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K, Ueda T, Uchino J, Hayasaka A, Shiramatsu K, Nagamachi Y, Shoda Y, Okui K, Hayata Y, Watanabe H.
    Jpn J Antibiot; 1987 Apr; 40(4):759-811. PubMed ID: 3302345
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of imipenem/cilastatin sodium against infections in compromised children (malignancy, hematological disease, collagen disease)].
    Nakano T, Itoh M, Sakurai M.
    Jpn J Antibiot; 1992 Aug; 45(8):1016-22. PubMed ID: 1433890
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M, Hirashima K.
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.